Acropolis Investment Management LLC Sells 207 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Acropolis Investment Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 10,920 shares of the healthcare conglomerate’s stock after selling 207 shares during the quarter. Acropolis Investment Management LLC’s holdings in UnitedHealth Group were worth $5,524,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Delta Financial Group Inc. grew its stake in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares during the period. First PREMIER Bank increased its stake in shares of UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 18 shares in the last quarter. Genesee Capital Advisors LLC boosted its stake in UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after acquiring an additional 18 shares in the last quarter. Jmac Enterprises LLC increased its stake in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares in the last quarter. Finally, Matrix Private Capital Group LLC boosted its position in shares of UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 19 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $543.76 on Wednesday. The stock has a 50-day simple moving average of $554.45 and a two-hundred day simple moving average of $563.12. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $500.41 billion, a PE ratio of 35.42, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business earned $6.56 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. UBS Group reduced their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.